PPA
HRMY icon

Parametric Portfolio Associates’s Harmony Biosciences HRMY Stock Holding History

Parametric Portfolio Associates’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$2.38M Buy
48,957
+25,605
+110% +$1.04M ﹤0.01% 2327
2021
Q4 		$996K Buy
23,352
+15,954
+216% +$636K ﹤0.01% 2787
2021
Q3 		$284K Buy
+7,398
New +$238K ﹤0.01% 3322

Other funds holding HRMY

VM
Valor Management Chicago, Illinois $86.2B AUM 12.66% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
VP
venBio Partners San Francisco, California $519M AUM 339.42% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Parametric Portfolio Associates's HRMY Position: Q1 2022 in Review

Parametric Portfolio Associates increased its Harmony Biosciences (HRMY) stake by 110% in Q1 2022, buying an estimated $1.04M and bringing the position to 48,957 shares worth $2.38M. The position accounts for ﹤0.01% of the portfolio, ranked #2327.

Parametric Portfolio Associates first reported a position in HRMY in Q3 2021 and has held it in 3 quarters since. 182 funds tracked by Wall St. Rank hold HRMY as of Q1 2022.

  • Parametric Portfolio Associates held 48,957 shares of Harmony Biosciences worth $2.38M as of Q1 2022.
  • Parametric Portfolio Associates bought 25,605 Harmony Biosciences shares in Q1 2022, an estimated $1.04M.
  • Harmony Biosciences made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #2327 holding.
  • Parametric Portfolio Associates first reported a position in Harmony Biosciences in Q3 2021 and has held it in 3 quarters since.
  • 182 funds tracked by Wall St. Rank held Harmony Biosciences as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.